Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome
收藏Figshare2016-01-15 更新2026-04-29 收录
下载链接:
https://figshare.com/articles/dataset/_Influenza_A_Virus_NS1_Protein_Inhibits_the_NLRP3_Inflammasome_/1417106
下载链接
链接失效反馈官方服务:
资源简介:
The inflammasome is a molecular platform that stimulates the activation of caspase-1 and the processing of pro-interleukin (IL)-1β and pro-IL-18 for secretion. The NOD-like receptor family, pyrin domain containing 3 (NLRP3) protein is activated by diverse molecules and pathogens, leading to the formation of the NLRP3 inflammasome. Recent studies showed that the NLRP3 inflammasome mediates innate immunity against influenza A virus (IAV) infection. In this study, we investigated the function of the IAV non-structural protein 1 (NS1) in the modulation of NLRP3 inflammasome. We found that NS1 proteins derived from both highly pathogenic and low pathogenic strains efficiently decreased secretion of IL-1β and IL-18 from THP-1 cells treated with LPS and ATP. NS1 overexpression significantly impaired the transcription of proinflammatory cytokines by inhibiting transactivation of the nuclear factor-κB (NF-κB), a major transcription activator. Furthermore, NS1 physically interacted with endogenous NLRP3 and activation of the NLRP3 inflammasome was abrogated in NS1-expressing THP-1 cells. These findings suggest that NS1 downregulates NLRP3 inflammasome activation by targeting NLRP3 as well as NF-κB, leading to a reduction in the levels of inflammatory cytokines as a viral immune evasion strategy.
炎性体(inflammasome)是一类可激活半胱天冬氨酸蛋白酶-1(caspase-1),并介导pro-白细胞介素-1β(pro-IL-1β)与pro-白细胞介素-18(pro-IL-18)加工及分泌的分子平台。核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)可被多种分子与病原体激活,进而组装形成NLRP3炎性体。近期研究表明,NLRP3炎性体可介导针对甲型流感病毒(IAV)感染的固有免疫应答。本研究探讨了甲型流感病毒非结构蛋白1(NS1)对NLRP3炎性体的调控作用。研究发现,高致病性与低致病性毒株来源的NS1蛋白,均可有效抑制经脂多糖(LPS)与三磷酸腺苷(ATP)处理的THP-1细胞中IL-1β与IL-18的分泌。NS1过表达可通过抑制核心转录激活因子核因子κB(NF-κB)的反式激活,显著削弱促炎细胞因子的转录水平。进一步实验显示,NS1可与内源性NLRP3发生物理相互作用;在表达NS1的THP-1细胞中,NLRP3炎性体的激活被完全阻断。上述结果提示,NS1可通过靶向NLRP3与NF-κB下调NLRP3炎性体的激活,进而降低炎性细胞因子水平,以此作为病毒的免疫逃逸策略。
创建时间:
2016-01-15



